Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2023-08-11 00:00:00 ET · period of report 2023-08-11 · accession 0000899243-23-018091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-11 | 2023-08-11 | DBD | Caldwell David Alan | EVP - Strategy, Corp Dev | J - Other | $0.00 | -211.1K | 0 | -100% | $0 |
| DM | 2023-08-11 | 2023-08-11 | DBD | Caldwell David Alan | EVP - Strategy, Corp Dev | J - Other | $0.00 | -43.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-08-11 | J | D | 211,068 | $0.00 | 0 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option | 2023-08-11 | J | D | 9,351 | $0.00 | 0 | D | $11.96 · 2021-01-30 to 2030-01-30 | 9,351 Common Shares | (F2) Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant. |
| 3 | Derivative | Non-Qualified Stock Option | 2023-08-11 | J | D | 33,929 | $0.00 | 0 | D | $4.08 · 2020-01-29 to 2029-01-29 | 33,929 Common Shares | (F2) Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant. |